Super Enjofil 160 Mg Tablet

Super Enjofil 160 Mg (Advanced Dual-Action Erectile Optimization & Ejaculatory Control Matrix)

Super Enjofil 160 Mg is a high-potency, pharmaceutical-grade oral intervention combining two clinically proven active compounds in a synchronized structural delivery system: Sildenafil Citrate (100mg) and Dapoxetine Hydrochloride (60mg). It is engineered for the clinical management of severe erectile dysfunction (ED) combined with premature ejaculation (PE) within adult male patient profiles. Utilizing an advanced dual-action mechanism, this formulation functions by concurrently modulating the competitive inhibition of cGMP-specific phosphodiesterase type 5 (PDE5) enzymes—facilitating deep smooth muscle relaxation and accelerated nitric oxide-mediated blood flow into the corpus cavernosum—and executing the targeted inhibition of the neuronal serotonin reuptake transporter (SERT). By neutralizing the physical and neurological triggers of localized vascular insufficiency and rapid ejaculatory signaling—specifically those induced by poor penile arterial perfusion, high-affinity PDE5 expression, or rapid synaptic serotonin clearance patterns—and facilitating the organized stabilization of the sexual response cycle through a high-purity molecular complex, Super Enjofil effectively promotes a significant optimization of erectile rigidity and a substantial expansion of intravaginal ejaculatory latency time (IELT). This targeted system action provides a decisive therapeutic response by reinforcing the physiological uniformity of pelvic hemodynamics while promoting a stable, physiological recovery from performance-related biological stressors.

Key Features

• Combines a high-potency peripheral vasodilator with a fast-acting neurological reuptake inhibitor to address physical erection quality and neurological ejaculatory timing in a single tablet.
• Features a high-affinity sildenafil configuration designed to optimize cyclic GMP levels, maximizing arterial blood flow and maintaining rock-hard cavernous structural rigidity.
• Employs a premium dapoxetine sequence clinically recognized for its ability to increase synaptic serotonin activity, effectively delaying the ejaculatory reflex arc.
• Acts as a functional structural catalyst to deliver rapid systemic absorption, significantly extending the duration of intimate encounters and lowering performance fatigue.
• Formulated as a smooth, film-coated solid tablet tailored to provide predictable metabolic release intervals, addressing dual reproductive parameters without causing structural tissue strain.

Key Active Constituents

• Sildenafil Citrate (100mg)
• Dapoxetine Hydrochloride (60mg)

How to Use

• The formulation must be administered orally. Ensure the physical structure of the film-coated tablet remains completely intact; do not crush, chew, or split the active matrix prior to the swallowing sequence.
• Administer 1 tablet precisely 1 hour to 3 hours prior to anticipated sexual activity to permit the dual chemical peaks to align perfectly within the bloodstream.
• Swallow the solid unit presentation whole with a full glass of clear water; it can be taken independently of food intake, though avoiding high-fat meals is recommended to prevent absorption delay markers.
• The maximum recommended application frequency is strictly 1 tablet within a 24-hour chronometric window; do not escalate the dosage parameters independently.
• Drink plenty of water throughout the active duration of the compound to support optimal systemic circulation and reduce secondary vascular flushing markers.
• Use strictly as an on-demand clinical intervention; do not introduce this high-potency tablet as a continuous daily maintenance therapy.

Precautions

• This is a high-potency, dual-action urological intervention. Continued deployment must be mapped out by a specialist following a formal comprehensive baseline evaluation of cardiovascular safety and blood pressure parameters.
• Never deploy this formulation concurrently with any form of organic nitrates (e.g., nitroglycerin, isosorbide dinitrate) or nitric oxide donors, as this can trigger a dangerous, catastrophic drop in systemic blood pressure parameters.
• Individuals presenting with a history of recent myocardial infarction (heart attack), stroke, severe cardiac arrhythmia, or unstable angina must undergo intensive screening before integration.
• Avoid concurrent use with Monoamine Oxidase Inhibitors (MAOIs), other SSRIs, thioridazine, or tricyclic antidepressants; allow a strict 14-day washout period to prevent serotonin syndrome anomalies.
• Discontinue use immediately and consult a specialist if you develop signs of acute vascular distress, sudden vision variations (non-arteritic anterior ischemic optic neuropathy), sudden hearing loss, or a painful erection lasting greater than 4 hours (priapism).
• Keep the blister packaging tightly sealed and store in a cool, dry place (below 30°C). Protect from moisture, high humidity zones, and direct sunlight to maintain complete molecular stability.

Warning

• Strictly engineered for digestive tract absorption; do not utilize for sublingual dissolution, crushing into food, or alternative unauthorized delivery pathways.
• If an erection persists beyond 4 hours, immediate emergency medical intervention must be sought to prevent permanent structural damage to the erectile tissue matrix.
• Avoid the consumption of heavy alcohol volumes or central nervous system sedatives while utilizing the tablet, as this amplifies orthostatic hypotension risks, dizziness, and somnolence.
• This formulation is strictly contraindicated for use by women, pediatric populations under 18 years of age, or individuals presenting with severe hepatic or renal impairment milestones.

Legal Disclaimer: Super Enjofil 160 Mg is a specialized prescription dual-action urological formulation. Individual structural outcomes, absorption timelines, and performance duration vary based on baseline vascular health, neurological parameters, and clinical adherence. This product is for use under professional medical guidance only. This information is for educational purposes and is not a substitute for formal professional medical consultation.